Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Cytotherapy|June 15, 2022
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatmentMaja Stanojevic, Alice Bertaina, Carmem Bonfim, et al.Cytotherapy|January 29, 2023
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineeringOrly R Klein, Carmem Bonfim, Allistair Abraham, et al.Internal Medicine Journal|November 1, 2020
Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experienceIan Nivison-Smith, Ashish Bajel, Anthony J Dodds, et al.Blood|September 4, 2014
Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practiceDuncan Purtill, Katherine Smith, Sean Devlin, et al.Internal Medicine Journal|October 20, 2021
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceGreg Hapgood, Maya Latimer, Sze Ting Lee, et al.Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2010
Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantationRegis Peffault de Latour, Duncan Purtill, Annalisa Ruggeri, et al.Leukemia & Lymphoma|July 16, 2019
Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western AustraliaJames A Kuzich, Andrew P Hutchison, Kenneth J C Lim, et al.BMC Cancer|March 24, 2025
Rehabilitation after bone marrow transplant compared with usual care to improve patient outcomes (REBOOT): protocol for a randomised controlled trialLinda Denehy, Shaza Abo, Christopher Swain, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid LeukemiaVanderson Rocha, Annalisa Ruggeri, Stephen Spellman, et al.Pageof 6